02427 GUANZE MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 5.64X | Oper Margin | 17.4% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 11.1% |
| Total Debt/Equity | 7.0% | Return on Equity | 6.6% |
| Price/Book | 1.65X | Return on Assets | 5.7% |
| (HKD 0.480) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 18.30 | 30.38 | 20.12 | 28.05 | 34.47 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -39.8 | +51.0 | -28.3 | -18.6 | +38.1 |
| Earnings Per Share (HKD) | 0.02 | 0.032 | 0.026 | 0.037 | N/A |
| Earnings Per Share Growth (%) | -39.1 | +21.7 | -28.9 | +100.0 | N/A |
| Dividend Per Share (HKD) | No dividend | 0.021 | 0.021 | No dividend | No dividend |
| P/E* (X) | 24.62 | 15.00 | 18.25 | 12.97 | N/A |
| Yield (%) | N/A | 4.38 | 4.38 | N/A | N/A |
| Dividend Share (%) | N/A | 65.63 | 79.85 | N/A | N/A |
| Book NAV (HKD) | 0.290 | 0.313 | 0.307 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 31.855 | 40.03 | -20.4 | 74.413 |
| Operating Result | 4.563 | 2.801 | +62.9 | 22.809 |
| Profit Before Taxation | 4.563 | 2.801 | +62.9 | 22.809 |
| Taxation | 1.125 | 2.938 | -61.7 | 6.683 |
| Profit /( Loss) After Taxation | 3.438 | -0.137 | -2,609.5 | 16.126 |
| Minority Interests | 0.07 | 0.023 | +204.3 | 0.178 |
| Net Profit | 3.368 | -0.16 | -2,205.0 | 15.948 |
| Earnings Per Share () | 0.0039 | -0.0002 | -2,050.0 | 0.0181 |
| Announcement Date | 2025-08-27 | 2024-08-26 | NA | 2023-08-24 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
